BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Mucopolysaccharidosis Type IIIA readouts · AssetMemo
X-WR-CALDESC:Upcoming phase 1/2 and later readouts in Mucopolysaccharidosis
  Type IIIA\, from ClinicalTrials.gov estimates.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT06181136-10789@assetmemo.bio
DTSTAMP:20261121T005019Z
DTSTART;VALUE=DATE:20320731
DTEND;VALUE=DATE:20320801
SUMMARY:DNL126: Phase 1/2 readout est. (NCT06181136)
DESCRIPTION:DNL126\, phase 1/2\, Mucopolysaccharidosis Type IIIA.\nStudy: S
 tudy of DNL126 in Pediatric Participants With Mucopolysaccharidosis Type I
 IIA (Sanfilippo Syndrome Type A)\nEstimated primary completion: July 2032.
  This is a ClinicalTrials.gov estimate\, not a confirmed readout date\, an
 d it can move.\nDrug page: https://assetmemo.bio/drug/dnl126#upcoming-even
 ts\nRegistry record: https://clinicaltrials.gov/study/NCT06181136
URL:https://assetmemo.bio/drug/dnl126#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
